Evidence map›Paper›PMID 38030230›Full record

ArticleRMD open2023

Characteristics and outcome of critically ill patients with systemic rheumatic diseases referred to the intensive care unit.

Mathias Schneeweiss-Gleixner, Caroline Hillebrand, Stephanie Jaksits, Jonathan Fries, Michael Zauner, Gottfried Heinz, Gürkan Sengölge, Thomas Staudinger, Christian Zauner, Daniel Aletaha and 3 more

Open access · goldAbstract read
In one paragraph

Article in RMD open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Mathias Schneeweiss-GleixnerClinical Division of Gastroenterology and Hepatology, Department of Medicine III, Intensive Care Unit 13.h1, Medical University of Vienna, Vienna, Austria.ORCID 0009-0001-5296-1212
Caroline HillebrandClinical Division of Rheumatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Stephanie JaksitsClinical Division of Rheumatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Jonathan FriesDepartment of Developmental and Educational Psychology, Faculty of Psychology, University of Vienna, Vienna, Austria.
Michael ZaunerClinical Division of Rheumatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Gottfried HeinzClinical Division of Cardiology, Department of Medicine II, Medical University of Vienna, Vienna, Austria.
Gürkan SengölgeClinical Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Thomas StaudingerIntensive Care Unit 13.i2, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Christian ZaunerClinical Division of Gastroenterology and Hepatology, Department of Medicine III, Intensive Care Unit 13.h1, Medical University of Vienna, Vienna, Austria.
Daniel AletahaClinical Division of Rheumatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.ORCID 0000-0003-2108-0030
Klaus P MacholdClinical Division of Rheumatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-9551-1975
Peter SchellongowskiIntensive Care Unit 13.i2, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Manuel BécèdeClinical Division of Rheumatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria manuel.becede@meduniwien.ac.at.ORCID 0009-0007-8469-7413
Medical University of Vienna · ATKarl Landsteiner Society · ATUniversity of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesPatients with systemic rheumatic diseases (SRDs) are at risk of admission to the intensive care unit (ICU). Data concerning these critically ill patients are limited to few retrospective studies.

methodsThis is a single-centre retrospective study of patients with SRDs admitted to an ICU at the Vienna General Hospital between 2012 and 2020. Single-predictor and multiple logistic regression analysis was performed to identify potential outcome determinants.

resultsA total of 144 patients accounting for 192 ICU admissions were included. Connective tissue diseases (CTDs), vasculitides and rheumatoid arthritis were the most common SRDs requiring ICU admission. Leading causes for ICU admission were respiratory failure and shock, as reflected by a high number of patients requiring mechanical ventilation (60.4%) and vasopressor therapy (72.9%). Overall, 29.2% of admissions were due to SRD-related critical illness. In 70.8% patients, co-existent SRD not responsible for the acute critical illness was documented. When comparing these subgroups, CTDs and vasculitides had a higher frequency in the patients with SRD-related critical illness. In a significantly higher proportion of patients in the SRD-related subgroup, diagnosis of SRD was made at the ICU. ICU and 6-month mortality in the overall population was 20.3% and 38.5%, respectively. Age, glucocorticoid therapy prior to hospital admission and disease severity were associated with poor outcome.

conclusionsIn this study, respiratory failure was the leading cause of ICU admission as reflected by high rates of required mechanical ventilation. Despite considerable severity of critical illness, survival rates were comparable to a general ICU population.

Indexed as

Respiratory InsufficiencyRheumatic DiseasesVasculitisCritical IllnessHumansIntensive Care UnitsRetrospective Studiesautoimmune diseasescardiovascular diseasesepidemiologyimmune system diseasesinflammation

Identifiers

PMID38030230
PMCPMC10689389
OpenAlexW4389132245

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.